$1.36
0.053.82%
最終更新: Oct 20, 12:14 PM
$1.33
0.021.53%
Benzinga
Benzinga
Benzinga
火曜日, 10 20
Benzinga
© 2026 Benzinga | All Rights Reserved
ProQR Therapeutics (PRQR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.14 | $-0.15 | $-0.08 | $-0.10 |
| Actual | $-0.09 | $-0.15 | $-0.09 | $-0.10 |
| Surprise | +35.7% | 0.00% | -12.5% | 0.00% |
| Revenue | ||||
| Estimate | $5.6M | $5.5M | $8.6M | $8.6M |
| Actual | $10.2M | $2.4M | $5.5M | $2.9M |
| Surprise | +83.2% | -56.9% | -36.2% | -66.3% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.11 | $-0.14 | $-0.16 | $-0.18 |
| Revenue | ||||
| Consensus | $5.3M | $5.0M | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-0.09 | $-0.14 | 35.7 % |
| Q1 | May 12, 2026 | $-0.15 | $-0.15 | 0.00 % |
| Q4 | Mar 12, 2026 | $-0.09 | $-0.08 | -12.5 % |
| Q3 | Nov 6, 2025 | $-0.10 | $-0.10 | 0.00 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $10.18M | $5.56M | 83.2 % |
| Q1 | May 12, 2026 | $2.38M | $5.53M | -56.9 % |
| Q4 | Mar 12, 2026 | $5.46M | $8.55M | -36.2 % |
| Q3 | Nov 6, 2025 | $2.88M | $8.55M | -66.3 % |